Cargando…

Therapeutic community drug treatment success in Peru: a follow-up outcome study

BACKGROUND: The purpose of this study was to assess the impact of drug abuse treatment in Peru that used the therapeutic community (TC) model. Program directors and several staff members from all study treatment facilities received two to eight weeks of in-country training on how to implement the TC...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Knowlton, Pan, Zhenfeng, Young, Linda, Vanderhoff, Jude, Shamblen, Steve, Browne, Thom, Linfield, Ken, Suresh, Geetha
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631528/
https://www.ncbi.nlm.nih.gov/pubmed/19055774
http://dx.doi.org/10.1186/1747-597X-3-26
_version_ 1782163940675944448
author Johnson, Knowlton
Pan, Zhenfeng
Young, Linda
Vanderhoff, Jude
Shamblen, Steve
Browne, Thom
Linfield, Ken
Suresh, Geetha
author_facet Johnson, Knowlton
Pan, Zhenfeng
Young, Linda
Vanderhoff, Jude
Shamblen, Steve
Browne, Thom
Linfield, Ken
Suresh, Geetha
author_sort Johnson, Knowlton
collection PubMed
description BACKGROUND: The purpose of this study was to assess the impact of drug abuse treatment in Peru that used the therapeutic community (TC) model. Program directors and several staff members from all study treatment facilities received two to eight weeks of in-country training on how to implement the TC treatment model prior to the follow-up study. METHODS: This outcome study involved 33 TC treatment facilities and 509 former clients in Lima and other cities in five providences across Peru. A retrospective pre-test (RPT) follow-up design was employed in which 30-day use of illegal drugs and alcohol to intoxication was measured at baseline retrospectively, at the same time of the six-month follow-up. In-person interview data were collected from directors of 73 percent of the eligible TC organizations in January and February 2003 and from former 58 percent of the eligible TC former clients between October 2003 and October 2004. Drug testing was conducted on a small sample of former clients to increase the accuracy of the self-reported drug use data. RESULTS: Medium to large positive treatment effects were found when comparing 30-day illegal drug and alcohol use to intoxication before and six months after receiving treatment. As a supplemental analysis, we assumed the 42 percent of the former clients who were not interviewed at the six month assessment had returned to drugs. These results showed medium treatment effects as well. Hierarchical Generalized Linear Modeling (HGLM) results showed higher implementation fidelity, less stigma after leaving treatment, and older clients, singly or in combination are key predictors of treatment success. CONCLUSION: This study found that former clients of drug and alcohol treatment in facilities using the TC model reported substantial positive change in use of illegal drugs and alcohol to intoxication at a six-month follow-up. The unique contribution of this study is that the results also suggest attention should be placed on the importance of implementing the TC drug abuse treatment model with fidelity. Further, the results strongly suggest that TC drug abuse treatment programs should incorporate follow-up activities that attempt to neutralize community negative reactions (perceived stigma) independent of other factors.
format Text
id pubmed-2631528
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26315282009-01-28 Therapeutic community drug treatment success in Peru: a follow-up outcome study Johnson, Knowlton Pan, Zhenfeng Young, Linda Vanderhoff, Jude Shamblen, Steve Browne, Thom Linfield, Ken Suresh, Geetha Subst Abuse Treat Prev Policy Research BACKGROUND: The purpose of this study was to assess the impact of drug abuse treatment in Peru that used the therapeutic community (TC) model. Program directors and several staff members from all study treatment facilities received two to eight weeks of in-country training on how to implement the TC treatment model prior to the follow-up study. METHODS: This outcome study involved 33 TC treatment facilities and 509 former clients in Lima and other cities in five providences across Peru. A retrospective pre-test (RPT) follow-up design was employed in which 30-day use of illegal drugs and alcohol to intoxication was measured at baseline retrospectively, at the same time of the six-month follow-up. In-person interview data were collected from directors of 73 percent of the eligible TC organizations in January and February 2003 and from former 58 percent of the eligible TC former clients between October 2003 and October 2004. Drug testing was conducted on a small sample of former clients to increase the accuracy of the self-reported drug use data. RESULTS: Medium to large positive treatment effects were found when comparing 30-day illegal drug and alcohol use to intoxication before and six months after receiving treatment. As a supplemental analysis, we assumed the 42 percent of the former clients who were not interviewed at the six month assessment had returned to drugs. These results showed medium treatment effects as well. Hierarchical Generalized Linear Modeling (HGLM) results showed higher implementation fidelity, less stigma after leaving treatment, and older clients, singly or in combination are key predictors of treatment success. CONCLUSION: This study found that former clients of drug and alcohol treatment in facilities using the TC model reported substantial positive change in use of illegal drugs and alcohol to intoxication at a six-month follow-up. The unique contribution of this study is that the results also suggest attention should be placed on the importance of implementing the TC drug abuse treatment model with fidelity. Further, the results strongly suggest that TC drug abuse treatment programs should incorporate follow-up activities that attempt to neutralize community negative reactions (perceived stigma) independent of other factors. BioMed Central 2008-12-03 /pmc/articles/PMC2631528/ /pubmed/19055774 http://dx.doi.org/10.1186/1747-597X-3-26 Text en Copyright © 2008 Johnson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Johnson, Knowlton
Pan, Zhenfeng
Young, Linda
Vanderhoff, Jude
Shamblen, Steve
Browne, Thom
Linfield, Ken
Suresh, Geetha
Therapeutic community drug treatment success in Peru: a follow-up outcome study
title Therapeutic community drug treatment success in Peru: a follow-up outcome study
title_full Therapeutic community drug treatment success in Peru: a follow-up outcome study
title_fullStr Therapeutic community drug treatment success in Peru: a follow-up outcome study
title_full_unstemmed Therapeutic community drug treatment success in Peru: a follow-up outcome study
title_short Therapeutic community drug treatment success in Peru: a follow-up outcome study
title_sort therapeutic community drug treatment success in peru: a follow-up outcome study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631528/
https://www.ncbi.nlm.nih.gov/pubmed/19055774
http://dx.doi.org/10.1186/1747-597X-3-26
work_keys_str_mv AT johnsonknowlton therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT panzhenfeng therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT younglinda therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT vanderhoffjude therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT shamblensteve therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT brownethom therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT linfieldken therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy
AT sureshgeetha therapeuticcommunitydrugtreatmentsuccessinperuafollowupoutcomestudy